【市場調査レポート】フィサレミンのグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Physalaemin Market Insights, Forecast to 2028

QYResearchが調査・発行した産業分析レポートです。フィサレミンのグローバル市場インサイト・予測（～2028年） / Global Physalaemin Market Insights, Forecast to 2028 / QY2207E10466資料のイメージです。

• レポートコード：QY2207E10466
• 出版社/出版日：QYResearch / 2022年7月
• レポート形態：英文、PDF、72ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥735,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,102,500 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,470,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

新型コロナウイルス感染症のパンデミックにより、世界のフィサレミンの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にフィサレミンの世界市場のxxx％を占める「95％以上」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「科学研究」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
中国のフィサレミンの市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのフィサレミン市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのフィサレミン市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

フィサレミンのグローバル主要メーカーには、Peptide Institute、Vivitideなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

フィサレミン市場は、種類と用途によって区分されます。世界のフィサレミン市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
95％以上、98％以上

【用途別セグメント】
科学研究、医療、その他

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- フィサレミン製品概要
- 種類別市場（95％以上、98％以上）
- 用途別市場（科学研究、医療、その他）
- 調査の目的
・エグゼクティブサマリー
- 世界のフィサレミン販売量予測2017-2028
- 世界のフィサレミン売上予測2017-2028
- フィサレミンの地域別販売量
- フィサレミンの地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別フィサレミン販売量
- 主要メーカー別フィサレミン売上
- 主要メーカー別フィサレミン価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（95％以上、98％以上）
- フィサレミンの種類別販売量
- フィサレミンの種類別売上
- フィサレミンの種類別価格
・用途別市場規模（科学研究、医療、その他）
- フィサレミンの用途別販売量
- フィサレミンの用途別売上
- フィサレミンの用途別価格
・北米市場
- 北米のフィサレミン市場規模（種類別、用途別）
- 主要国別のフィサレミン市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパのフィサレミン市場規模（種類別、用途別）
- 主要国別のフィサレミン市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋のフィサレミン市場規模（種類別、用途別）
- 主要国別のフィサレミン市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米のフィサレミン市場規模（種類別、用途別）
- 主要国別のフィサレミン市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカのフィサレミン市場規模（種類別、用途別）
- 主要国別のフィサレミン市場規模（トルコ、サウジアラビア）
・企業情報
Peptide Institute、Vivitide
・産業チェーン及び販売チャネル分析
- フィサレミンの産業チェーン分析
- フィサレミンの原材料
- フィサレミンの生産プロセス
- フィサレミンの販売及びマーケティング
- フィサレミンの主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- フィサレミンの産業動向
- フィサレミンのマーケットドライバー
- フィサレミンの課題
- フィサレミンの阻害要因
・主な調査結果

Market Analysis and Insights: Global Physalaemin Market
Due to the COVID-19 pandemic, the global Physalaemin market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Above 95% accounting for % of the Physalaemin global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Scientific Research segment is altered to an % CAGR throughout this forecast period.
China Physalaemin market size is valued at US$ million in 2021, while the US and Europe Physalaemin are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Physalaemin landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Physalaemin include Peptide Institute and Vivitide etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Physalaemin Scope and Segment
Physalaemin market is segmented by Purity and by Application. Players, stakeholders, and other participants in the global Physalaemin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Purity and by Application for the period 2017-2028.
Segment by Purity
Above 95%
Above 98%
Segment by Application
Scientific Research
Medical
Others
By Company
Peptide Institute
Vivitide
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

1 Study Coverage
1.1 Physalaemin Product Introduction
1.2 Market by Purity
1.2.1 Global Physalaemin Market Size Growth Rate by Purity, 2017 VS 2021 VS 2028
1.2.2 Above 95%
1.2.3 Above 98%
1.3 Market by Application
1.3.1 Global Physalaemin Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Scientific Research
1.3.3 Medical
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Physalaemin Sales Estimates and Forecasts 2017-2028
2.2 Global Physalaemin Revenue Estimates and Forecasts 2017-2028
2.3 Global Physalaemin Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Physalaemin Sales by Region
2.4.1 Global Physalaemin Sales by Region (2017-2022)
2.4.2 Global Sales Physalaemin by Region (2023-2028)
2.5 Global Physalaemin Revenue by Region
2.5.1 Global Physalaemin Revenue by Region (2017-2022)
2.5.2 Global Physalaemin Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Physalaemin Sales by Manufacturers
3.1.1 Global Top Physalaemin Manufacturers by Sales (2017-2022)
3.1.2 Global Physalaemin Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Physalaemin in 2021
3.2 Global Physalaemin Revenue by Manufacturers
3.2.1 Global Physalaemin Revenue by Manufacturers (2017-2022)
3.2.2 Global Physalaemin Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Physalaemin Revenue in 2021
3.3 Global Physalaemin Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Physalaemin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Physalaemin Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Purity
4.1 Global Physalaemin Sales by Purity
4.1.1 Global Physalaemin Historical Sales by Purity (2017-2022)
4.1.2 Global Physalaemin Forecasted Sales by Purity (2023-2028)
4.1.3 Global Physalaemin Sales Market Share by Purity (2017-2028)
4.2 Global Physalaemin Revenue by Purity
4.2.1 Global Physalaemin Historical Revenue by Purity (2017-2022)
4.2.2 Global Physalaemin Forecasted Revenue by Purity (2023-2028)
4.2.3 Global Physalaemin Revenue Market Share by Purity (2017-2028)
4.3 Global Physalaemin Price by Purity
4.3.1 Global Physalaemin Price by Purity (2017-2022)
4.3.2 Global Physalaemin Price Forecast by Purity (2023-2028)
5 Market Size by Application
5.1 Global Physalaemin Sales by Application
5.1.1 Global Physalaemin Historical Sales by Application (2017-2022)
5.1.2 Global Physalaemin Forecasted Sales by Application (2023-2028)
5.1.3 Global Physalaemin Sales Market Share by Application (2017-2028)
5.2 Global Physalaemin Revenue by Application
5.2.1 Global Physalaemin Historical Revenue by Application (2017-2022)
5.2.2 Global Physalaemin Forecasted Revenue by Application (2023-2028)
5.2.3 Global Physalaemin Revenue Market Share by Application (2017-2028)
5.3 Global Physalaemin Price by Application
5.3.1 Global Physalaemin Price by Application (2017-2022)
5.3.2 Global Physalaemin Price Forecast by Application (2023-2028)
6 North America
6.1 North America Physalaemin Market Size by Purity
6.1.1 North America Physalaemin Sales by Purity (2017-2028)
6.1.2 North America Physalaemin Revenue by Purity (2017-2028)
6.2 North America Physalaemin Market Size by Application
6.2.1 North America Physalaemin Sales by Application (2017-2028)
6.2.2 North America Physalaemin Revenue by Application (2017-2028)
6.3 North America Physalaemin Market Size by Country
6.3.1 North America Physalaemin Sales by Country (2017-2028)
6.3.2 North America Physalaemin Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Physalaemin Market Size by Purity
7.1.1 Europe Physalaemin Sales by Purity (2017-2028)
7.1.2 Europe Physalaemin Revenue by Purity (2017-2028)
7.2 Europe Physalaemin Market Size by Application
7.2.1 Europe Physalaemin Sales by Application (2017-2028)
7.2.2 Europe Physalaemin Revenue by Application (2017-2028)
7.3 Europe Physalaemin Market Size by Country
7.3.1 Europe Physalaemin Sales by Country (2017-2028)
7.3.2 Europe Physalaemin Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Physalaemin Market Size by Purity
8.1.1 Asia Pacific Physalaemin Sales by Purity (2017-2028)
8.1.2 Asia Pacific Physalaemin Revenue by Purity (2017-2028)
8.2 Asia Pacific Physalaemin Market Size by Application
8.2.1 Asia Pacific Physalaemin Sales by Application (2017-2028)
8.2.2 Asia Pacific Physalaemin Revenue by Application (2017-2028)
8.3 Asia Pacific Physalaemin Market Size by Region
8.3.1 Asia Pacific Physalaemin Sales by Region (2017-2028)
8.3.2 Asia Pacific Physalaemin Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Physalaemin Market Size by Purity
9.1.1 Latin America Physalaemin Sales by Purity (2017-2028)
9.1.2 Latin America Physalaemin Revenue by Purity (2017-2028)
9.2 Latin America Physalaemin Market Size by Application
9.2.1 Latin America Physalaemin Sales by Application (2017-2028)
9.2.2 Latin America Physalaemin Revenue by Application (2017-2028)
9.3 Latin America Physalaemin Market Size by Country
9.3.1 Latin America Physalaemin Sales by Country (2017-2028)
9.3.2 Latin America Physalaemin Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Physalaemin Market Size by Purity
10.1.1 Middle East and Africa Physalaemin Sales by Purity (2017-2028)
10.1.2 Middle East and Africa Physalaemin Revenue by Purity (2017-2028)
10.2 Middle East and Africa Physalaemin Market Size by Application
10.2.1 Middle East and Africa Physalaemin Sales by Application (2017-2028)
10.2.2 Middle East and Africa Physalaemin Revenue by Application (2017-2028)
10.3 Middle East and Africa Physalaemin Market Size by Country
10.3.1 Middle East and Africa Physalaemin Sales by Country (2017-2028)
10.3.2 Middle East and Africa Physalaemin Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Peptide Institute
11.1.1 Peptide Institute Corporation Information
11.1.2 Peptide Institute Overview
11.1.3 Peptide Institute Physalaemin Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Peptide Institute Physalaemin Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Peptide Institute Recent Developments
11.2 Vivitide
11.2.1 Vivitide Corporation Information
11.2.2 Vivitide Overview
11.2.3 Vivitide Physalaemin Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Vivitide Physalaemin Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Vivitide Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Physalaemin Industry Chain Analysis
12.2 Physalaemin Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Physalaemin Production Mode & Process
12.4 Physalaemin Sales and Marketing
12.4.1 Physalaemin Sales Channels
12.4.2 Physalaemin Distributors
12.5 Physalaemin Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Physalaemin Industry Trends
13.2 Physalaemin Market Drivers
13.3 Physalaemin Market Challenges
13.4 Physalaemin Market Restraints
14 Key Findings in The Global Physalaemin Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Physalaemin Market Size Growth Rate by Purity, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Above 95%
Table 3. Major Manufacturers of Above 98%
Table 4. Global Physalaemin Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Physalaemin Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Physalaemin Sales by Region (2017-2022) & (K Units)
Table 7. Global Physalaemin Sales Market Share by Region (2017-2022)
Table 8. Global Physalaemin Sales by Region (2023-2028) & (K Units)
Table 9. Global Physalaemin Sales Market Share by Region (2023-2028)
Table 10. Global Physalaemin Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Physalaemin Revenue Market Share by Region (2017-2022)
Table 12. Global Physalaemin Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Physalaemin Revenue Market Share by Region (2023-2028)
Table 14. Global Physalaemin Sales by Manufacturers (2017-2022) & (K Units)
Table 15. Global Physalaemin Sales Share by Manufacturers (2017-2022)
Table 16. Global Physalaemin Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Physalaemin Revenue Share by Manufacturers (2017-2022)
Table 18. Physalaemin Price by Manufacturers (2017-2022) &(US$/Unit)
Table 19. Global Physalaemin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Physalaemin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Physalaemin as of 2021)
Table 21. Physalaemin Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Physalaemin Product Offered
Table 23. Date of Manufacturers Enter into Physalaemin Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Physalaemin Sales by Purity (2017-2022) & (K Units)
Table 26. Global Physalaemin Sales by Purity (2023-2028) & (K Units)
Table 27. Global Physalaemin Sales Share by Purity (2017-2022)
Table 28. Global Physalaemin Sales Share by Purity (2023-2028)
Table 29. Global Physalaemin Revenue by Purity (2017-2022) & (US$ Million)
Table 30. Global Physalaemin Revenue by Purity (2023-2028) & (US$ Million)
Table 31. Global Physalaemin Revenue Share by Purity (2017-2022)
Table 32. Global Physalaemin Revenue Share by Purity (2023-2028)
Table 33. Physalaemin Price by Purity (2017-2022) & (US$/Unit)
Table 34. Global Physalaemin Price Forecast by Purity (2023-2028) & (US$/Unit)
Table 35. Global Physalaemin Sales by Application (2017-2022) & (K Units)
Table 36. Global Physalaemin Sales by Application (2023-2028) & (K Units)
Table 37. Global Physalaemin Sales Share by Application (2017-2022)
Table 38. Global Physalaemin Sales Share by Application (2023-2028)
Table 39. Global Physalaemin Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Physalaemin Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Physalaemin Revenue Share by Application (2017-2022)
Table 42. Global Physalaemin Revenue Share by Application (2023-2028)
Table 43. Physalaemin Price by Application (2017-2022) & (US$/Unit)
Table 44. Global Physalaemin Price Forecast by Application (2023-2028) & (US$/Unit)
Table 45. North America Physalaemin Sales by Purity (2017-2022) & (K Units)
Table 46. North America Physalaemin Sales by Purity (2023-2028) & (K Units)
Table 47. North America Physalaemin Revenue by Purity (2017-2022) & (US$ Million)
Table 48. North America Physalaemin Revenue by Purity (2023-2028) & (US$ Million)
Table 49. North America Physalaemin Sales by Application (2017-2022) & (K Units)
Table 50. North America Physalaemin Sales by Application (2023-2028) & (K Units)
Table 51. North America Physalaemin Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Physalaemin Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Physalaemin Sales by Country (2017-2022) & (K Units)
Table 54. North America Physalaemin Sales by Country (2023-2028) & (K Units)
Table 55. North America Physalaemin Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Physalaemin Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Physalaemin Sales by Purity (2017-2022) & (K Units)
Table 58. Europe Physalaemin Sales by Purity (2023-2028) & (K Units)
Table 59. Europe Physalaemin Revenue by Purity (2017-2022) & (US$ Million)
Table 60. Europe Physalaemin Revenue by Purity (2023-2028) & (US$ Million)
Table 61. Europe Physalaemin Sales by Application (2017-2022) & (K Units)
Table 62. Europe Physalaemin Sales by Application (2023-2028) & (K Units)
Table 63. Europe Physalaemin Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Physalaemin Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Physalaemin Sales by Country (2017-2022) & (K Units)
Table 66. Europe Physalaemin Sales by Country (2023-2028) & (K Units)
Table 67. Europe Physalaemin Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Physalaemin Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Physalaemin Sales by Purity (2017-2022) & (K Units)
Table 70. Asia Pacific Physalaemin Sales by Purity (2023-2028) & (K Units)
Table 71. Asia Pacific Physalaemin Revenue by Purity (2017-2022) & (US$ Million)
Table 72. Asia Pacific Physalaemin Revenue by Purity (2023-2028) & (US$ Million)
Table 73. Asia Pacific Physalaemin Sales by Application (2017-2022) & (K Units)
Table 74. Asia Pacific Physalaemin Sales by Application (2023-2028) & (K Units)
Table 75. Asia Pacific Physalaemin Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Physalaemin Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Physalaemin Sales by Region (2017-2022) & (K Units)
Table 78. Asia Pacific Physalaemin Sales by Region (2023-2028) & (K Units)
Table 79. Asia Pacific Physalaemin Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Physalaemin Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Physalaemin Sales by Purity (2017-2022) & (K Units)
Table 82. Latin America Physalaemin Sales by Purity (2023-2028) & (K Units)
Table 83. Latin America Physalaemin Revenue by Purity (2017-2022) & (US$ Million)
Table 84. Latin America Physalaemin Revenue by Purity (2023-2028) & (US$ Million)
Table 85. Latin America Physalaemin Sales by Application (2017-2022) & (K Units)
Table 86. Latin America Physalaemin Sales by Application (2023-2028) & (K Units)
Table 87. Latin America Physalaemin Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Physalaemin Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Physalaemin Sales by Country (2017-2022) & (K Units)
Table 90. Latin America Physalaemin Sales by Country (2023-2028) & (K Units)
Table 91. Latin America Physalaemin Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Physalaemin Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Physalaemin Sales by Purity (2017-2022) & (K Units)
Table 94. Middle East and Africa Physalaemin Sales by Purity (2023-2028) & (K Units)
Table 95. Middle East and Africa Physalaemin Revenue by Purity (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Physalaemin Revenue by Purity (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Physalaemin Sales by Application (2017-2022) & (K Units)
Table 98. Middle East and Africa Physalaemin Sales by Application (2023-2028) & (K Units)
Table 99. Middle East and Africa Physalaemin Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Physalaemin Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Physalaemin Sales by Country (2017-2022) & (K Units)
Table 102. Middle East and Africa Physalaemin Sales by Country (2023-2028) & (K Units)
Table 103. Middle East and Africa Physalaemin Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Physalaemin Revenue by Country (2023-2028) & (US$ Million)
Table 105. Peptide Institute Corporation Information
Table 106. Peptide Institute Description and Major Businesses
Table 107. Peptide Institute Physalaemin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 108. Peptide Institute Physalaemin Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Peptide Institute Recent Developments
Table 110. Vivitide Corporation Information
Table 111. Vivitide Description and Major Businesses
Table 112. Vivitide Physalaemin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 113. Vivitide Physalaemin Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Vivitide Recent Developments
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Physalaemin Distributors List
Table 118. Physalaemin Customers List
Table 119. Physalaemin Market Trends
Table 120. Physalaemin Market Drivers
Table 121. Physalaemin Market Challenges
Table 122. Physalaemin Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Physalaemin Product Picture
Figure 3. Global Physalaemin Market Share by Purity in 2021 & 2028
Figure 3. Above 95% Product Picture
Figure 4. Above 98% Product Picture
Figure 5. Global Physalaemin Market Share by Application in 2021 & 2028
Figure 6. Scientific Research
Figure 7. Medical
Figure 8. Others
Figure 9. Physalaemin Report Years Considered
Figure 10. Global Physalaemin Sales 2017-2028 (K Units)
Figure 11. Global Physalaemin Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Physalaemin Revenue 2017-2028 (US$ Million)
Figure 13. Global Physalaemin Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 14. Global Physalaemin Sales Market Share by Region (2017-2022)
Figure 15. Global Physalaemin Sales Market Share by Region (2023-2028)
Figure 16. North America Physalaemin Sales YoY (2017-2028) & (K Units)
Figure 17. North America Physalaemin Revenue YoY (2017-2028) & (US$ Million)
Figure 18. Europe Physalaemin Sales YoY (2017-2028) & (K Units)
Figure 19. Europe Physalaemin Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Asia-Pacific Physalaemin Sales YoY (2017-2028) & (K Units)
Figure 21. Asia-Pacific Physalaemin Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Latin America Physalaemin Sales YoY (2017-2028) & (K Units)
Figure 23. Latin America Physalaemin Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Middle East & Africa Physalaemin Sales YoY (2017-2028) & (K Units)
Figure 25. Middle East & Africa Physalaemin Revenue YoY (2017-2028) & (US$ Million)
Figure 26. The Physalaemin Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 27. The Top 5 and 10 Largest Manufacturers of Physalaemin in the World: Market Share by Physalaemin Revenue in 2021
Figure 28. Global Physalaemin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 29. Global Physalaemin Sales Market Share by Purity (2017-2028)
Figure 30. Global Physalaemin Revenue Market Share by Purity (2017-2028)
Figure 31. Global Physalaemin Sales Market Share by Application (2017-2028)
Figure 32. Global Physalaemin Revenue Market Share by Application (2017-2028)
Figure 33. North America Physalaemin Sales Market Share by Purity (2017-2028)
Figure 34. North America Physalaemin Revenue Market Share by Purity (2017-2028)
Figure 35. North America Physalaemin Sales Market Share by Application (2017-2028)
Figure 36. North America Physalaemin Revenue Market Share by Application (2017-2028)
Figure 37. North America Physalaemin Sales Share by Country (2017-2028)
Figure 38. North America Physalaemin Revenue Share by Country (2017-2028)
Figure 39. United States Physalaemin Revenue (2017-2028) & (US$ Million)
Figure 40. Canada Physalaemin Revenue (2017-2028) & (US$ Million)
Figure 41. Europe Physalaemin Sales Market Share by Purity (2017-2028)
Figure 42. Europe Physalaemin Revenue Market Share by Purity (2017-2028)
Figure 43. Europe Physalaemin Sales Market Share by Application (2017-2028)
Figure 44. Europe Physalaemin Revenue Market Share by Application (2017-2028)
Figure 45. Europe Physalaemin Sales Share by Country (2017-2028)
Figure 46. Europe Physalaemin Revenue Share by Country (2017-2028)
Figure 47. Germany Physalaemin Revenue (2017-2028) & (US$ Million)
Figure 48. France Physalaemin Revenue (2017-2028) & (US$ Million)
Figure 49. U.K. Physalaemin Revenue (2017-2028) & (US$ Million)
Figure 50. Italy Physalaemin Revenue (2017-2028) & (US$ Million)
Figure 51. Russia Physalaemin Revenue (2017-2028) & (US$ Million)
Figure 52. Asia Pacific Physalaemin Sales Market Share by Purity (2017-2028)
Figure 53. Asia Pacific Physalaemin Revenue Market Share by Purity (2017-2028)
Figure 54. Asia Pacific Physalaemin Sales Market Share by Application (2017-2028)
Figure 55. Asia Pacific Physalaemin Revenue Market Share by Application (2017-2028)
Figure 56. Asia Pacific Physalaemin Sales Share by Region (2017-2028)
Figure 57. Asia Pacific Physalaemin Revenue Share by Region (2017-2028)
Figure 58. China Physalaemin Revenue (2017-2028) & (US$ Million)
Figure 59. Japan Physalaemin Revenue (2017-2028) & (US$ Million)
Figure 60. South Korea Physalaemin Revenue (2017-2028) & (US$ Million)
Figure 61. India Physalaemin Revenue (2017-2028) & (US$ Million)
Figure 62. Australia Physalaemin Revenue (2017-2028) & (US$ Million)
Figure 63. China Taiwan Physalaemin Revenue (2017-2028) & (US$ Million)
Figure 64. Indonesia Physalaemin Revenue (2017-2028) & (US$ Million)
Figure 65. Thailand Physalaemin Revenue (2017-2028) & (US$ Million)
Figure 66. Malaysia Physalaemin Revenue (2017-2028) & (US$ Million)
Figure 67. Latin America Physalaemin Sales Market Share by Purity (2017-2028)
Figure 68. Latin America Physalaemin Revenue Market Share by Purity (2017-2028)
Figure 69. Latin America Physalaemin Sales Market Share by Application (2017-2028)
Figure 70. Latin America Physalaemin Revenue Market Share by Application (2017-2028)
Figure 71. Latin America Physalaemin Sales Share by Country (2017-2028)
Figure 72. Latin America Physalaemin Revenue Share by Country (2017-2028)
Figure 73. Mexico Physalaemin Revenue (2017-2028) & (US$ Million)
Figure 74. Brazil Physalaemin Revenue (2017-2028) & (US$ Million)
Figure 75. Argentina Physalaemin Revenue (2017-2028) & (US$ Million)
Figure 76. Middle East and Africa Physalaemin Sales Market Share by Purity (2017-2028)
Figure 77. Middle East and Africa Physalaemin Revenue Market Share by Purity (2017-2028)
Figure 78. Middle East and Africa Physalaemin Sales Market Share by Application (2017-2028)
Figure 79. Middle East and Africa Physalaemin Revenue Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Physalaemin Sales Share by Country (2017-2028)
Figure 81. Middle East and Africa Physalaemin Revenue Share by Country (2017-2028)
Figure 82. Turkey Physalaemin Revenue (2017-2028) & (US$ Million)
Figure 83. Saudi Arabia Physalaemin Revenue (2017-2028) & (US$ Million)
Figure 84. UAE Physalaemin Revenue (2017-2028) & (US$ Million)
Figure 85. Physalaemin Value Chain
Figure 86. Physalaemin Production Process
Figure 87. Channels of Distribution
Figure 88. Distributors Profiles
Figure 89. Bottom-up and Top-down Approaches for This Report
Figure 90. Data Triangulation
Figure 91. Key Executives Interviewed

以下、関連資料のご紹介

高純度アルキル化剤のグローバル市場インサイト・予測（～2028年）

Global High Purity Alkylating Agent Market Insights, Forecast to 2028
QY2207E10370 2022年7月 70Pages
新型コロナウイルス感染症のパンデミックにより、世界の高純度アルキル化剤の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に高純度アルキル化剤...

高純度リドカインのグローバル市場インサイト・予測（～2028年）

Global High Purity Lidocaine Market Insights, Forecast to 2028
QY2207E10371 2022年7月 94Pages
新型コロナウイルス感染症のパンデミックにより、世界の高純度リドカインの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に高純度リドカインの世...

アジュバントペプチドのグローバル市場インサイト・予測（～2028年）

Global Adjuvant Peptide Market Insights, Forecast to 2028
QY2207E09212 2022年7月 75Pages
新型コロナウイルス感染症のパンデミックにより、世界のアジュバントペプチドの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にアジュバントペプ...

統合失調症関連ペプチドのグローバル市場インサイト・予測（～2028年）

Global Schizophrenia Related Peptide Market Insights, Forecast to 2028
QY2207E10485 2022年7月 79Pages
新型コロナウイルス感染症のパンデミックにより、世界の統合失調症関連ペプチドの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に統合失調症関連...

血清胸腺因子のグローバル市場インサイト・予測（～2028年）

Global Serum Thymic Factor Market Insights, Forecast to 2028
QY2207E09283 2022年7月 90Pages
新型コロナウイルス感染症のパンデミックにより、世界の血清胸腺因子の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に血清胸腺因子の世界市場の...

バソトシンのグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global Vasotocin Market Due to the COVID-19 pandemic, the global Vasotocin market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the e…
アジュバントペプチドのグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global Adjuvant Peptide Market The global Adjuvant Peptide market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028. Fully considering the economic change by this health crisis, Above 95% accounting for % of the Ad…
高純度アルキル化剤のグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global High Purity Alkylating Agent Market Due to the COVID-19 pandemic, the global High Purity Alkylating Agent market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast per…
高純度リドカインのグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global High Purity Lidocaine Market Due to the COVID-19 pandemic, the global High Purity Lidocaine market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028.…
統合失調症関連ペプチドのグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global Schizophrenia Related Peptide Market Due to the COVID-19 pandemic, the global Schizophrenia Related Peptide market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast p…